Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_assertion type Assertion NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_head.
- NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_assertion description "[Our finding of comparable rate of TMPRSS2-ERG fusion in minute adenocarcinomas may argue against its value as a marker of aggressive prostate carcinoma phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_provenance.
- NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_assertion evidence source_evidence_literature NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_provenance.
- NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_assertion SIO_000772 19734849 NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_provenance.
- NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_assertion wasDerivedFrom befree-2016 NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_provenance.
- NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_assertion wasGeneratedBy ECO_0000203 NP761662.RAwWbg2WgvCbfyBPhXQ6Gkpl1CMeYDR994NjHoX4jVlEE130_provenance.